Union health ministry will soon roll out an indigenously developed diagnostic test called "Truenat test" for effective case detection of Tuberculosis (TB).This point-of-care (POC)...
India is mulling the introduction of a home-grown, battery-operated, point-of-care test that can detect tuberculosis in under an hour and phase out smear microscopy...
Indigenously developed point-of-care (POC) molecular diagnostic test validated through multicentric studies and found to be comparable with internationally approved molecular diagnostic test...
India, with its high tuberculosis (TB) and multi-drug resistant tuberculosis (MDR-TB) burden, has long been lookingfor an affordable, high-sensitivity test to be used in the most peripheral health facilities with least technical complexity...
Truenat MTB is being tested in 100 microscopy centres in 10 States A cheaper, indigenously developed molecular diagnostic test for drug-sensitive and rifampicin-resistant TB is entering the final leg of performance validation and operational feasibility testing...
Scientists from the Indian Council for Medical Research (ICMR) are working on an indigenous DNA-based sputum test for tuberculosis (TB) and drug resistant TB, which will bring down the cost of TB test by at least half...
TrueNat TB, a new molecular test that can diagnose Tuberculosis (TB) in one hour as well as testing for resistance to the drug rifampicin, developed by Molbio Diagnostics has been awarded BioSpectrum Product of the year award 2020. Sriram Natarajan, Chief Executive Officer, Molbio Diagnostics, Goa received the award at a virtual ceremony held in March 2021. The ceremony witnessed the participation of over 200 industry leaders from across the country.
In a unique cross-industry collaboration, Qure.ai, Molbio Diagnostics, Fujifilm Corporation and Toyota Tsusho have come together for a TB detection program named 'Driving to find the missing millions'
